> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Sanofi Pays $12 Million to Settle ‘False Claims’
- URL: https://www.fdaweb.com/sanofi-pays-12-million-to-settle-false-claims/
- Published: 2020-03-02T12:00:00.000Z
- Updated: 2026-09-14T16:05:13.000Z
- Author: David McFarland
- Tags: Drugs, FDA Policy/General, #legacy-id-D5146217

Sanofi-Aventis has agreed to pay almost $12 million to resolve allegations that it violated the False Claims Act by paying kickbacks to Medicare patients taking its multiple sclerosis drug Lemtrada through a purportedly independent charitable foundation, The Assistance Fund. The Anti-Kickback Statute prohibits drug companies from offering or paying to induce Medicare patients to purchase its drugs.  
  
“According to the allegations in today’s settlement agreement, Sanofi used a supposed charity as a conduit to funnel money to patients taking Sanofi’s very expensive drug, all at the expense of the Medicare program,” said Boston-based U.S. Attorney **Andrew E. Lelling**. “Sanofi sought to undermine the Medicare program through its use of kickbacks disguised as routine charitable donations aimed at helping patients battling multiple sclerosis and who were struggling with costly copays,” the government said in a [**release**](https://www.justice.gov/usao-ma/pr/sanofi-agrees-pay-1185-million-resolve-allegations-it-paid-kickbacks-through-co-pay?ref=fdaweb.com).